Dominari Holdings Inc.

NasdaqCM:DOMH Stock Report

Market Cap: US$12.0m

Dominari Holdings Management

Management criteria checks 2/4

Dominari Holdings' CEO is Anthony Hayes, appointed in Sep 2013, has a tenure of 11.08 years. total yearly compensation is $1,000.00K, comprised of 50% salary and 50% bonuses, including company stock and options. directly owns 7.87% of the company’s shares, worth $943.45K. The average tenure of the management team and the board of directors is 1.8 years and 4.1 years respectively.

Key information

Anthony Hayes

Chief executive officer

US$1.0m

Total compensation

CEO salary percentage50.0%
CEO tenure11.1yrs
CEO ownership7.9%
Management average tenure1.8yrs
Board average tenure4.1yrs

Recent management updates

Recent updates

AIkido continues to buyback more shares

Oct 05

AIkido Pharma's subsidiary agrees to buy broker-dealer firm

Sep 12

Alkido Pharma shareholders proposes to acquire company at $8/share in cash

Aug 09

AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans

May 04
AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans

AIkido Pharma: Advancing Anticancer And Antiviral Therapies

Feb 10

AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans

Jan 14
AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About AIkido Pharma's (NASDAQ:AIKI) Cash Burn Situation

Sep 29
Here's Why We're Not Too Worried About AIkido Pharma's (NASDAQ:AIKI) Cash Burn Situation

We Think AIkido Pharma (NASDAQ:AIKI) Can Easily Afford To Drive Business Growth

Jun 05
We Think AIkido Pharma (NASDAQ:AIKI) Can Easily Afford To Drive Business Growth

AIkido Pharma's stock surges on psilocybin patent license agreement

Jan 06

CEO Compensation Analysis

How has Anthony Hayes's remuneration changed compared to Dominari Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$22m

Mar 31 2024n/an/a

-US$25m

Dec 31 2023US$1mUS$500k

-US$23m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$26m

Mar 31 2023n/an/a

-US$23m

Dec 31 2022US$2mUS$500k

-US$26m

Sep 30 2022n/an/a

-US$21m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021US$960kUS$460k

-US$7m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$8m

Dec 31 2020US$1mUS$395k

-US$12m

Sep 30 2020n/an/a

-US$12m

Jun 30 2020n/an/a

-US$13m

Mar 31 2020n/an/a

-US$11m

Dec 31 2019US$350kUS$350k

-US$4m

Sep 30 2019n/an/a

US$346k

Jun 30 2019n/an/a

US$2m

Mar 31 2019n/an/a

US$2m

Dec 31 2018US$349kUS$349k

US$2m

Sep 30 2018n/an/a

-US$5m

Jun 30 2018n/an/a

-US$2m

Mar 31 2018n/an/a

-US$4m

Dec 31 2017US$931kUS$349k

-US$3m

Compensation vs Market: Anthony's total compensation ($USD1,000.00K) is above average for companies of similar size in the US market ($USD666.73K).

Compensation vs Earnings: Anthony's compensation has been consistent with company performance over the past year.

CEO

Anthony Hayes (56 yo)

11.1yrs

Tenure

US$1,000,000

Compensation

Mr. Anthony C. Hayes, Esq. has been the Chief Executive Officer at Dominari Holdings Inc. (formerly known as AIkido Pharma Inc.) (formerly known as Spherix Incorporated)) since September 10, 2013 and serve...

Leadership Team

NamePositionTenureCompensationOwnership
Anthony Hayes
CEO & Chairman11.1yrsUS$1.00m7.87%
$ 943.4k
Kyle Wool
President & Directorless than a yearUS$600.36k6.69%
$ 801.7k
Soo Yu
Director & Special Projects Managerno dataUS$8.31m19.81%
$ 2.4m
Christopher Devall
Chief Operating Officer1.8yrsUS$397.60k0.48%
$ 57.4k
Jaime Mercado
Chief Compliance Officerno datano datano data

1.8yrs

Average Tenure

49.5yo

Average Age

Experienced Management: DOMH's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Anthony Hayes
CEO & Chairman11.1yrsUS$1.00m7.87%
$ 943.4k
Kyle Wool
President & Director3.5yrsUS$600.36k6.69%
$ 801.7k
Soo Yu
Director & Special Projects Manager2.3yrsUS$8.31m19.81%
$ 2.4m
Robert Vander Zanden
Chairman Emeritusno dataUS$65.00kno data
Timothy Ledwick
Independent Director9.3yrsUS$65.00k0.16%
$ 18.9k
Scott Tagawa
Member of Scientific Advisory Board3.7yrsno datano data
Gregory Blattner
Independent Director6.4yrsUS$65.00k0.15%
$ 18.1k
Kyle Haug
Independent Directorless than a yearUS$10.83kno data
Robert Dudley
Independent Director4.5yrsUS$65.00k0.15%
$ 18.1k

4.1yrs

Average Tenure

54.5yo

Average Age

Experienced Board: DOMH's board of directors are considered experienced (4.1 years average tenure).